Muno-IgY® is developed for brands and practitioners seeking a non-systemic, non-pharmacological approach to gut and immune support.

Rather than attempting to eliminate microbes or broadly reshape the microbiome, Muno-IgY® is positioned to:

• Interact with microbial targets within the gut lumen
• Support immune homeostasis at the mucosal surface
• Complement existing gut health strategies, including probiotics, prebiotics, dietary fibers, and lifestyle interventions

This approach reflects emerging thinking around microbial pressure and gut resilience, particularly in individuals with sensitive or highly reactive digestive systems.

• Food-grade IgY extracted from egg yolk
• Non-systemic, localized activity in the gastrointestinal tract
• Gentle, solvent-free extraction process
• High purity with defined IgY content
• Stable in capsule and powder formats
• Suitable for vegetarian (ovo-vegetarian) formulations

Muno-IgY® is intended for use as a supporting ingredient in formulations focused on:

• Digestive comfort and gut function
• Immune support linked to gut health
• Microbial balance within the gastrointestinal tract
• Practitioner-guided gut health protocols

It is designed to integrate alongside established gut health ingredients rather than replace them.

Muno-IgY® is supported by a growing body of scientific literature on IgY, along with ongoing and planned studies focused on gut health applications and quality-of-life outcomes.

Our evidence strategy is designed to support ingredient buyer confidence, formulation decisions, and downstream brand education—recognizing that ingredient adoption requires clarity across R&D, regulatory, marketing, and practitioner stakeholders.

Specific study details and summaries are available upon request.

• Produced under controlled manufacturing conditions
• Batch-tested for identity, purity, and quality parameters
• No chemical solvents used in extraction
• Designed for scalability and global B2B supply

Sustainability is integrated into the process, with egg yolk material responsibly returned to the food system following IgY extraction.

IGY Life Sciences works with ingredient buyers, practitioner brands, compounders, and distributors globally to support responsible innovation in gut and immune health. To request technical documentation, samples, or partnership discussions, please contact us using the form below.

Muno-IgY® is available as a bulk IgY ingredient for dietary supplement brands seeking a differentiated, evidence-informed component for gut and immune health formulations.

Supplied in scalable bulk formats, Muno-IgY® is designed for integration into capsules, powders, and multi-ingredient systems, and to complement established gut health ingredients.

Technical specifications, formulation guidance, and market-specific regulatory information are available upon request.

IGY Life Sciences offers white-label finished product options for practitioner brands and health-focused companies seeking a faster path to market.

White-label program includes:

• High-purity Muno-IgY® capsules (15 mg active IgY per capsule)
• Standard 60-count premium HDPE bottle with cap & desiccant (30 Day Supply)
• Access to professional science decks, white papers, and marketing assets for both clinicians and consumers

White-label availability may vary by market and regulatory pathway.

Muno-IgY® is well suited for compounding pharmacy use, where individualized formulations and practitioner oversight are central to patient care.

For compounding partners, IGY Life Sciences provides:

• Ingredient specifications and technical documentation

• Support for magistral formulation discussions

• Education on IgY’s role in gut-focused protocols

• Coordination with compounding distributors where applicable

Use of Muno-IgY® in compounded preparations is subject to local regulations and professional judgment.